Skip navigation
Home
About Us
Finance
Life Science & Healthcare
Life Science & Healthcare
Technology
Contact
All
TVM Capital News
Life Sciences News
Technology News
TVM Capital
Media Resources
Background Information
TVM Capital Life Science and Healthcare General Information
Veranstaltungsdokumentation: Wie kann der pharmazeutische Mittelstand überleben? (PDF - bitte per E-Mail anfordern / please request by email)
Thought Leadership – TVM Capital Spotlight Series
Selected Publications
Von der Pipeline- zur Projektfinanzierung: Fluch und Segen effizienter Finanzierungsstrategien
, by Dr. Hubert Birner
Nature Biotechnology: Investor volatility plagues drug companies on new Chinese exchange
(with contribution by General Partner Hui Hsing Ma)
Die Pharmaindustrie in Mitteldeutschland
, eine Veröffentlichung der Sachsenbank, Januar 2010
Eine Verbindung mit Zukunft. Neue Modelle der Frühphasenfinanzierung von Biotechnologie-Unternehmen
, by Dr. Hubert Birner
Chancen für mittelständische Unternehmen im Gesundheitsmarkt
, by Dr. Christoph Schröder and Dr. Kia Parssanedjad
Going Public Biotech Edition 2007
Images
TVM Capital Headquarter in Munich (JPG, 1200x878)
Hubert Birner at BIO-Europe 2009 in Vienna #1 (JPG, 640x426)
Hubert Birner at BIO-Europe 2009 in Vienna #2 (JPG, 640x426)
Axel Polack at BioPartnering, London 2009 (JPG, 500x334)
TVM Capital starts operation of its first regional healthcare growth capital fund in the Dubai International Financial Centre (DIFC), from left to right: Kevin Berkitt, Dr. Helmut Schühsler, Hoda Abou Jamra, Abdulla Mohammed Al Awar, Marios Fotiadis, Youssef Haidar (JPG, 3154x1874)
More Information
Life Science & Healthcare
News
Strategy & Portfolio
Thought Leadership
Media Resources
TVM Capital MENA
Investor Login
Marketing/PR Europe
Monika Schlesinger
+49 (89) 998992-0
schlesinger @ tvm-capital.de
Marketing/PR USA
Nancy Saucier
+1 (617) 345 9320
saucier @ tvm-capital.com